SCHEMBL23974251

SCHEMBL23974251

CC(=O)Nc1ccc(C(F)(F)F)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 1/20 0.54
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.50
KIF11 P52732 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
EPHX1 P07099 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
HSD17B10 Q99714 1/20 0.47
IDH1 O75874 1/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.46
KDR P35968 1/20 0.46
PDK2 Q15119 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5561662 0.86 MAP2K1 (0.54) MAP2K1ALDH1A1L3MBTL1KIF11TDP1
SCHEMBL10227598 0.84 ALDH1A1 (0.58) ALDH1A1L3MBTL1TDP1SMN1; SMN2HSD17B10
SCHEMBL19765580 0.84 MAP2K1 (0.49) MAP2K1ALDH1A1L3MBTL1KIF11EPHX1
SCHEMBL1192735 0.83 MAP2K1 (0.54) MAP2K1L3MBTL1KIF11EPHX1SMN1; SMN2
SCHEMBL20096581 0.81 EPHX1 (0.57) MAP2K1ALDH1A1L3MBTL1KIF11EPHX1
SCHEMBL28875490 0.81 KDR (0.57) MAP2K1ALDH1A1L3MBTL1KIF11EPHX1
SCHEMBL17988061 0.81 MAP2K1 (0.55) MAP2K1ALDH1A1L3MBTL1KIF11EPHX1
SCHEMBL5987928 0.80 ALDH1A1 (0.54) ALDH1A1L3MBTL1TDP1SMN1; SMN2HSD17B10
SCHEMBL463590 0.79 AR (0.62) MAP2K1ALDH1A1L3MBTL1KIF11EPHX1
SCHEMBL9807561 0.79 MAP2K1 (0.54) MAP2K1ALDH1A1L3MBTL1KIF11TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219090-A1 QUINOXALINE DIONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN 北京泰德制药股份有限公司 (CN) 2021-11-04 WO disclosed